Detalhe da pesquisa
1.
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
Nature
; 594(7862): 271-276, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910229
2.
Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling.
Arterioscler Thromb Vasc Biol
; 44(6): 1246-1264, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38660801
3.
Transcriptomic signatures of individual cell types in cerebral cavernous malformation.
Cell Commun Signal
; 22(1): 23, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195510
4.
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.
Stroke
; 54(11): 2906-2917, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746705
5.
ß1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations.
FASEB J
; 36(12): e22629, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349990
6.
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.
Nature
; 545(7654): 305-310, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28489816
7.
Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth.
J Magn Reson Imaging
; 55(5): 1440-1449, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558140
8.
Novel Murine Models of Cerebral Cavernous Malformations.
Angiogenesis
; 23(4): 651-666, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710309
9.
Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
J Autoimmun
; 113: 102469, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362501
10.
The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.
FASEB J
; 33(2): 2132-2143, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252535
11.
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
Circ Res
; 122(12): 1716-1721, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720384
12.
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
Stroke
; 50(3): 738-744, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30744543
13.
Phenotypic characterization of murine models of cerebral cavernous malformations.
Lab Invest
; 99(3): 319-330, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29946133
14.
Corrigendum to "Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu" [J. Autoimmun. 113 (2020) 102469].
J Autoimmun
; : 103116, 2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748978
15.
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
Stroke
; 48(1): 187-194, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27879448
16.
Propranolol as therapy for cerebral cavernous malformations: a cautionary note.
J Transl Med
; 20(1): 160, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382850
17.
Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation.
Brain Sci
; 13(9)2023 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759937
18.
Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in Cerebral Cavernous Malformations.
Nat Commun
; 14(1): 7009, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919320
19.
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma.
Commun Med (Lond)
; 3(1): 35, 2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869161
20.
Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.
Transl Stroke Res
; 14(4): 513-529, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715588